You're currently viewing an old version of this dataset. To see the current version, click here.

Malawi Integrated HIV Program Report 2021 Q3

Program performance highlights by the end of September 2021 include:

  • Scale-up of integrated HIV services had reached the following number of sites: * 760 static and 160 outreach HIV testing sites. * 767 (static) ART sites; 612 of these started at least one pregnant or breastfeeding woman. * 706 sites with HIV-exposed children in follow-up.
  • 642,325 persons were tested for HIV by a trained provider and received their results; 115,831 (18%) accessed HIV testing for the first time; 526,492 (82%) were repeat testers and 20,665 (4%) of these received confirmatory testing (after having tested positive in the past). 18,568 (3.0%) clients received a positive result for the first time.
  • A total of 142,158 people received 235,133 self-test kits; 110,183 (45%) of these were for use by the recipient and 124,950 (55%) for onward distribution to sex partners or other people.
  • 22,397 (98%) of 22,902 blood units collected were screened for (at least) HIV, hepatitis B and syphilis.
  • A cumulative total of 5,905 clients were referred for PrEP eligibility screening and 5,579 (94%) were found eligible. 4,750 (85%) were enrolled to on PrEP and 3,839 (81%) clients were retained on PrEP at the end of the September 2021.
  • 156,552 (96%) of 163,446 women at ANC had their HIV status ascertained; 8,885 (6%) of these were HIV positive. 137,258 (95%) of 145,024 at maternity had their HIV status ascertained 8,713 (6%) of these were HIV positive.
  • 18,792 patients started ART this quarter; 87% were classified as asymptomatic / in WHO stage 1 and started under the “Test & Treat” policy.
  • 887,338 patients were alive and on ART by end of September 2021. This means that 90% of the estimated 986,654 HIV positive population was on ART. ART coverage was 79% (45,504/ 54,686) for children and 89% (844,834 / 931,968) for adults.
  • 95,002 (93%) of viral load results from routine monitoring were <1000 copies/ml. Viral suppression rates for routine samples among children (0-14 years) and adults (15+ years) were 73% and 93%, respectively.
  • 79% of adults and 81% of children were retained alive on ART at 12 months after initiation.
  • Out of 874,993 patients on first line adult ART 840,657 (97%) had transitioned to TDF/3TC/DTG and only 2,450 (<1%) were on TDF/3TC/EFV.
  • 9,385 6 (99%) of an estimated 9,5513 HIV infected pregnant women in Malawi were on ART this quarter. 6,751 (71%) of these were already on ART when getting pregnant and 2,634 (29%) started ART during pregnancy/delivery.
  • An additional 722 breastfeeding women (re-)started ART in WHO stage 1 or 2.

Data and Resources

Additional Info

Field Value
Program Area Care and Treatment
Year 2021
Author
Author Email